20572-01-4

Basic information

• Product Name: 1-METHYL-1H-BENZIMIDAZOLE-2-CARBOXYLIC ACID
• Synonyms: 1-METHYLBENZIMIDAZOLE-2-CARBOXYLIC ACID;1-METHYL-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID;1-METHYL-1H-BENZIMIDAZOLE-2-CARBOXYLIC ACID;CHEMBRDG-BB 4400229;RARECHEM AX KI 0001;1H-Benzimidazole-2-carboxylicacid,1-methyl-(9CI);1-Methyl-1H-1,3-benzodiazole-2-carboxylic acid;1-Methyl-1H-benzo[d]iMidazole-2-carboxylic acid
• CAS NO: 20572-01-4
• Molecular Formula: C₉H₈N₂O₂
• Molecular Weight: 176.17
• Product Categories: BENZIMIDAZOLE
• Mol File: 20572-01-4.mol
• Article Data: 8

Chemical Properties

• Melting Point: 146.5
• Boiling Point: 403.6 °C at 760 mmHg
• Flash Point: 197.9 °C
• Appearance: /
• Density: 1.35 g/cm³
• Vapor Pressure: 3.07E-07mmHg at 25°C
• Refractive Index: 1.653
• PKA: 1.19±0.30(Predicted)
• CAS DataBase Reference: 1-METHYL-1H-BENZIMIDAZOLE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 1-METHYL-1H-BENZIMIDAZOLE-2-CARBOXYLIC ACID(20572-01-4)
• EPA Substance Registry System: 1-METHYL-1H-BENZIMIDAZOLE-2-CARBOXYLIC ACID(20572-01-4)

Safety Data

• Hazard Codes: Xi:Irritant
• Statements: R36/37/38:Irritating to eyes, respiratory system and skin.
• Safety Statements: S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S37/39:Wear suitable g
• Hazardous Substances Data: 20572-01-4(Hazardous Substances Data)

Usage

General Description

1-Methyl-1H-benzimidazole-2-carboxylic acid is a chemical compound with the molecular formula C9H8N2O2. It is a derivative of benzimidazole and is commonly used as a building block in the synthesis of pharmaceutical drugs and agrochemicals. 1-METHYL-1H-BENZIMIDAZOLE-2-CARBOXYLIC ACID has a carboxylic acid functional group, which makes it a useful intermediate for the production of various drugs and other organic compounds. It is also known for its potential biological activities, including anti-inflammatory and anti-tumor properties. Additionally, 1-Methyl-1H-benzimidazole-2-carboxylic acid has been investigated for its potential use as a corrosion inhibitor in the oil and gas industry. Overall, this compound has important applications in drug discovery and chemical research.

InChI:InChI=1/C9H8N2O2/c1-11-7-5-3-2-4-6(7)10-8(11)9(12)13/h2-5H,1H3,(H,12,13)

Upstream product

• 124-38-9 carbon dioxide 
• 2849-93-6 2-benzimidazolecarboxylic acid 
• 2849-92-5 methyl 1-methyl-1H-benzo[d]imidazole-2-carboxylate 
• 5805-53-8 BICA methyl ester 
• 3584-65-4 2-trichloromethyl-1H-benzoimidazole 
• 95-54-5 1,2-diamino-benzene 
• 1632-83-3 1-Methylbenzimidazole 
• 51-17-2 benzoimidazole 
• 57301-63-0 2-<1'-(Diphenylacetoxy)-2',2'-diphenylethenyl>-1-methyl-benzimidazole 
• 67162-12-3 2-(α-methylstyryl)benzimidazole 
• 14754-42-8 2-ethyl-1-methyl-1H-benzo[d]imidazole 
• 1848-84-6 2-ethylbenzimidazole 
• 336181-49-8 1-methyl-2-α-methylstyrylbenzimidazole 
• 57301-77-6 2-(Diphenylacetyl)-1-methylbenzimidazole 

Downstream Products

• 1349862-70-9 (1-methyl-1H-benzoimidazol-2-yl)-[3-(3-phenylpyrazin-2-yl)azetidin-1-yl]methanone 
• 1312556-86-7 (S)-N,1-dimethyl-N-(1-phenyl-4-(picolinamido)butan-2-yl)-1H-benzo[d]imidazole-2-carboxamide 
• 1312556-81-2 {(S)-1-benzyl-3-[(1-methyl-1H-benzoimidazole-2-carbonyl)amino]propyl}(methyl)carbamic acid tert-butyl ester 
• 1181571-75-4 1-methyl-1H-benzoimidazole-2-carboxylic acid [(1R,3S,4S)-2-(2-dimethylamino-5-phenyl-thiazole-4-carbonyl)-2-aza-bicyclo[2.2.1]hept-3-ylmethyl]-amide 
• 62366-47-6 1-methyl-1H-benzimidazole-2-carbonyl chloride 
• 1632-83-3 1-Methylbenzimidazole 

Relevant articles and documents

INHIBITORS OF MYOCARDIN-RELATED TRANSCRIPTION FACTOR AND SERUM RESPONSE FACTOR (MRTF/SRF)-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME

Disclosed herein are inhibitors of gene transcription mediated by myocardin-related transcription factor and serum response factor, or both myocardin-related transcription factor and serum response factor ("MRTF/SRF"), and methods for their use in treating or preventing cancer and fibrosis. In particular, disclosed herein are compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts thereof: wherein the substituents are as described.

NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS

Unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

Thienopyridine kinase inhibitors

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.